SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that Patent No. 7,226,429 has been issued to Aethlon Medical by the United States Patent and Trademark Office (USPTO). The patent, “Method for Removal of Viruses from Blood by Lectin Affinity Hemodialysis,” is integral to Aethlon’s intellectual property portfolio as it defines methods that allow the Aethlon Hemopurifier® to selectively capture a broad-spectrum of viruses from blood.
